Information Provided By: 
Fly News Breaks for April 27, 2016
CYNO
Apr 27, 2016 | 08:09 EDT
Leerink analyst Richard Newitter raised his price target for Cynosure to $60 from $53 following a "solid" Q1 revenue and EPS beat. The analyst says he has confidence that key new product cycles will continue to build momentum, with potential to drive further upside. Over the long run, the company should be a prime beneficiary of rising global trends toward less invasive cosmetic procedures, Newitter tells investors in a research note. The analyst reiterates an Outperform rating on the shares.
News For CYNO From the Last 2 Days
There are no results for your query CYNO
